Becton, Dickinson and Company Website

Becton, Dickinson and Company

NYSE-BDX

RevenueSep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22

Medication Delivery Solutions Revenue

4,575

4,520

Medication Management Solutions Revenue

3,474

3,439

Diabetes Care Revenue

—

—

Pharmaceutical Systems Revenue

2,324

2,299

Advanced Patient Monitoring Revenue

1,082

880

Specimen Management Revenue

1,871

1,850

Diagnostic Solusions Revenue

1,837

1,820

Integrated Diagnostic Solutions Revenue

3,708

3,670

Biosciences Revenue

1,458

1,468

Surgery Revenue

1,573

1,541

Peripheral Intervention Revenue

1,996

1,968

Urology and Critical Care Revenue

1,648

1,601

Other Revenue

2

—

Total Revenue

21,840

21,386

Revenue by GeographySep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22

United States Revenue

12,790

12,486

International Revenue

9,049

8,901

Other Revenue by Geography

1

-1

Total Revenue by Geography

21,840

21,386

RevenueSep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22

Medical Revenue

11,457

11,139

Life Sciences Revenue

5,166

5,138

Interventional Revenue

5,216

5,109

Other Revenue

1

—

Total Revenue

21,840

21,386

EBITSep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22

Medical Segment Operating Income (Pre-FY2025 Reporting)

—

2,714

Life Sciences Segment Operating Income (Pre-FY2025 Reporting)

—

1,572

Interventional Segment Operating Income (Pre-FY2025 Reporting)

—

1,531

Other EBIT

—

-3,314

Total EBIT

2,579

2,503